Get the Stockscreener App
4.94
2.37%
-0.12
After Hours:
4.91
-0.03
-0.61%
Ardelyx Inc stock is traded at $4.94, with a volume of 3.77M.
It is down -2.37% in the last 24 hours and down -25.60% over the past month.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
See More
Previous Close:
$5.06
Open:
$5.05
24h Volume:
3.77M
Relative Volume:
1.03
Market Cap:
$1.19B
Revenue:
$386.15M
Net Income/Loss:
$-56.39M
P/E Ratio:
-21.48
EPS:
-0.23
Net Cash Flow:
$-55.19M
1W Performance:
-6.08%
1M Performance:
-25.60%
6M Performance:
+16.24%
1Y Performance:
-18.21%
1-Day Range:
$4.86
$5.05
1-Week Range:
$4.86
$5.33
52-Week Range:
$3.21
$6.78
Ardelyx Inc Stock (ARDX) Company Profile
Name
Ardelyx Inc
Sector
Industry
Phone
510-745-7047
Address
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
4.94 | 1.22B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Resumed | Raymond James | Strong Buy |
| Jun-18-25 | Resumed | H.C. Wainwright | Buy |
| May-02-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-07-25 | Resumed | Ladenburg Thalmann | Buy |
| Mar-04-25 | Initiated | BTIG Research | Buy |
| Nov-11-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-02-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-05-24 | Initiated | Leerink Partners | Outperform |
| Dec-18-23 | Initiated | Raymond James | Strong Buy |
| Sep-07-23 | Initiated | H.C. Wainwright | Buy |
| Aug-25-23 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-03-23 | Upgrade | Wedbush | Neutral → Outperform |
| Nov-17-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| May-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-01-21 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Oct-14-21 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jul-21-21 | Downgrade | Jefferies | Buy → Hold |
| Jul-20-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-21 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-23-21 | Initiated | Wedbush | Outperform |
| Jan-06-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-20-20 | Resumed | Citigroup | Buy |
| Feb-18-20 | Resumed | Jefferies | Buy |
| Feb-12-20 | Initiated | Citigroup | Buy |
| Feb-10-20 | Initiated | Cowen | Outperform |
| Apr-08-19 | Initiated | Piper Jaffray | Overweight |
| Aug-24-18 | Initiated | Jefferies | Buy |
| Mar-19-18 | Resumed | Leerink Partners | Outperform |
| Nov-29-17 | Reiterated | Citigroup | Buy |
| Nov-22-17 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-17-17 | Resumed | Leerink Partners | Outperform |
| Mar-31-16 | Initiated | Ladenburg Thalmann | Buy |
| Mar-09-16 | Initiated | Cantor Fitzgerald | Buy |
| Mar-03-16 | Initiated | Citigroup | Buy |
View All
Ardelyx Inc Stock (ARDX) Latest News
Will Ardelyx Inc. continue its uptrendMarket Sentiment Summary & Smart Investment Allocation Tips - newser.com
Measuring Ardelyx Inc.’s beta against major indices2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com
Is Ardelyx Inc. stock attractive for ETFsJuly 2025 Highlights & Capital Protection Trade Alerts - newser.com
Will Ardelyx Inc. stock go up soon2025 Sector Review & Safe Entry Zone Tips - newser.com
What to do if you’re stuck in Ardelyx Inc.M&A Rumor & Technical Pattern Based Signals - newser.com
Why Ardelyx Inc. (41X) stock signals breakout potentialMarket Risk Summary & Expert Verified Movement Alerts - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Ardelyx (NASDAQ:ARDX) - MarketBeat
Using Python tools to backtest Ardelyx Inc. strategies2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - newser.com
What analysts say about Ardelyx Inc stockGlobal Market Influence & Free Discover Breakout Stocks Early - earlytimes.in
Ardelyx, Inc. (NASDAQ:ARDX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Ardelyx (NASDAQ:ARDX) Share Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Short interest data insights for Ardelyx Inc.Weekly Investment Summary & Low Volatility Stock Recommendations - newser.com
Detecting price anomalies in Ardelyx Inc. with AI2025 Year in Review & Fast Gain Swing Trade Alerts - newser.com
Can Ardelyx Inc. hit a new high this monthJuly 2025 Decliners & Breakout Confirmation Alerts - newser.com
Real time scanner hits for Ardelyx Inc. explained2025 Support & Resistance & Intraday High Probability Setup Alerts - newser.com
Reversal indicators forming on Ardelyx Inc. stockWeekly Earnings Recap & Low Risk Investment Opportunities - newser.com
Volatility clustering patterns for Ardelyx Inc.Bear Alert & Fast Gain Swing Alerts - newser.com
Ardelyx Inc Stock Analysis and ForecastEconomic Impact on Stocks & Free Trend Following Techniques - earlytimes.in
Is Ardelyx Inc. forming a reversal patternTrade Analysis Summary & Community Verified Swing Trade Signals - newser.com
Will Ardelyx Inc. rebound enough to break evenTake Profit & Risk Controlled Daily Trade Plans - newser.com
Ardelyx, Inc. Stock Hits Day Low of $5.49 Amid Price Pressure - Markets Mojo
Ardelyx Becomes Oversold (ARDX) - Nasdaq
What drives Ardelyx Inc 41X stock priceDay Trading Setups & Machine Learning Stock Picks, Daily - earlytimes.in
Ardelyx, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Ardelyx, Inc. Hits Day Low of $5.49 Amid Price Pressure - Markets Mojo
What drives JPMPRL stock priceEconomic Indicators Overview & Small Budget Portfolio Growth - earlytimes.in
What drives Ardelyx Inc stock priceChart Pattern Recognition & Receive Monthly Expert Trading Blueprints - earlytimes.in
Ardelyx (ARDX) Is Down 10.8% After Raising 2025 Sales Guidance – What's Changed - simplywall.st
Ardelyx (ARDX) Gets a Buy from Raymond James - The Globe and Mail
Ardelyx Inc Stock (ARDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ardelyx Inc Stock (ARDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Williams Laura A | Chief Patient Officer |
Aug 26 '25 |
Sale |
6.12 |
80,000 |
489,680 |
366,322 |
| Kelliher Mike | Chief Business Officer |
Aug 21 '25 |
Sale |
5.93 |
5,417 |
32,132 |
276,741 |
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):